|
시장보고서
상품코드
2013013
농약 시장 : 제품 유형, 성질, 작물 유형, 제형, 용도별 - 세계 예측(2026-2032년)Agrochemicals Market by Product Type, Nature, Crop Type, Formulation, Application - Global Forecast 2026-2032 |
||||||
360iResearch
농약 시장은 2025년에 910억 달러로 평가되었습니다. 2026년에는 960억 2,000만 달러로 성장하고 CAGR 6.75%를 나타내, 2032년까지 1,437억 9,000만 달러에 이를 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도(2025년) | 910억 달러 |
| 추정 연도(2026년) | 960억 2,000만 달러 |
| 예측 연도(2032년) | 1,437억 9,000만 달러 |
| CAGR(%) | 6.75% |
농업에서 작물 보호는 여전히 세계 식량 안보와 공급망 안정성을 뒷받침하는 기본 요소입니다. 농약 및 관련 화학물질은 해충, 병원균, 경쟁 식물에 의한 복합적인 압력으로부터 수확량을 보호하는 반면, 제형 과학과 살포 기술은 그 효과와 환경에 미치는 영향에 영향을 미칩니다. 최근 몇 년 동안 이 업계는 규제 당국의 감시, 지속가능성에 대한 기대, 기술 혁신이 빠르게 융합되어 제품 개발, 등록 및 현장 도입 방식에 새로운 형태를 가져오고 있습니다.
농약 산업은 기술 발전, 규제 강화, 변화하는 고객의 기대치가 결합되어 혁신적인 변화를 겪고 있습니다. 정밀 농업 기술은 더 이상 실험적인 부가 기능이 아니라 살포 프로토콜에 점점 더 통합되어 활성 성분의 보다 표적화된 사용을 가능하게 하고 비표적에 대한 영향을 줄이고 있습니다. 이러한 통합은 가변 속도 살포, 드론 및 스마트 분무기와의 호환성, 탱크 믹스의 안정성 향상에 대한 수요를 촉진했습니다. 그 결과, 제품 개발은 이제 본질적인 유효성뿐만 아니라 데이터 호환성과 디지털 통합의 용이성을 중요하게 여기게 되었습니다.
2025년에 도입된 농약 원료에 영향을 미치는 관세 및 무역 장벽은 전체 가치사슬의 조달 패턴, 공급망 전략 및 비용 구조에 실질적인 변화를 가져왔습니다. 특정 활성 성분 및 제제 중간체에 대한 수입 관세로 인해 많은 기존 합성 제품의 선적 비용이 상승하여 구매자는 공급업체와의 관계를 재검토하고 공급처 다변화를 가속화해야 했습니다. 그 결과, 조달팀은 기존 지배적인 무역 경로 이외의 대체 공급업체 선정에 집중하는 한편, 주요 제조업체들은 치솟는 국경 간 비용에 대한 영향을 줄이기 위해 생산의 국내 회귀(리쇼어링)와 지역 분산화를 모색하고 있습니다.
부문 수준의 동향은 업계 전체의 제품 개발 및 시장 출시 선택에 영향을 미치는 미묘한 기회와 압력을 드러내고 있습니다. 제품 유형 중 살균제는 디티오카르바메이트, 스트로빌린, 트리아졸 등 기존 화학물질로 분류되며, 각각 다른 내성 프로파일과 적용 시기를 가지고 있어 포트폴리오의 우선순위에 영향을 미치고 있습니다. 제초제는 발아 전과 발아 후 두 가지 측면에서 평가되며, 발아 후 처리제는 선택적 및 비선택적 작용기전에 따라 더욱 구분됩니다. 이러한 세부적인 분류는 생산자가 잡초 저항성 관리와 작물 안전 및 수확량 최적화의 균형을 맞추는 데 있어 매우 중요합니다. 살충제 세분화에서 카르바마트계, 네오니코티노이드계, 유기인계, 피레스로이드계 등 활성 성분 클래스의 다양성이 두드러지며, 이는 서로 다른 규제 및 관리 전략을 주도하고 있습니다. 한편, 쥐약은 환경적 위험과 비표적 생물에 대한 위험에 대한 고려사항이 다른 항응고제와 비항응고제 접근 방식에 여전히 초점을 맞추었습니다.
지역별 동향은 광범위한 지리적 클러스터에 따라 크게 다르며, 단기적인 상업적 우선순위와 장기적인 역량 투자에 영향을 미치고 있습니다. 미주 지역에서는 농업 시스템에서 대규모 기계화 농업과 주식 작물이 중시되는 경우가 많아 고효능 합성 농약과 적응성이 높은 제형에 대한 안정적인 수요가 발생하고 있습니다. 동시에 소매업체와 식품 가공업체들의 지속가능성에 대한 노력은 공급업체들에게 저잔류 대안과 견고한 관리 프로그램을 제공하도록 압력을 가하고 있으며, 그 결과 농학, 자문 서비스, 제품 공급을 결합한 통합 솔루션의 채택을 촉진하고 있습니다. 통합 솔루션의 채택이 촉진되고 있습니다.
각 회사의 전략은 경쟁과 규제 압력에 대한 광범위한 대응을 반영하고 있으며, 업계 리더는 포트폴리오 다각화, 타겟팅된 인수, 역량 강화를 결합하여 추진하고 있습니다. 일부 조직은 자체 지적재산을 확보하고 외부 공급업체에 대한 의존도를 낮추기 위해 미생물 발견 플랫폼과 자체 발효 설비에 대한 투자를 통해 바이오 제품 파이프라인을 확장하는 데 주력하고 있습니다. 또 다른 기업들은 제제 기술의 우수성에 중점을 두고 전문 제제 제조업체를 인수하거나 제휴하여 정밀 살포 장면에서 효과를 발휘하는 복합 제제나 저용량 제품을 제공합니다.
업계 리더는 이 분야의 복잡성을 효과적으로 극복하기 위해 R&D, 공급망, 규제 당국과의 협력 및 상업적 실행을 통합적으로 조정하는 통합적 접근 방식을 채택해야 합니다. 우선, 무역 혼란에 대한 노출을 줄이고 보충 주기를 단축하기 위해 유효 성분공급원과 지역적 제조 능력의 다양화를 우선적으로 고려해야 합니다. 모듈식 생산 능력에 대한 투자와 전략적 위탁생산 파트너십을 통해 유연성을 확보하고 리드타임 리스크를 줄이는 동시에 우선순위가 높은 화학물질 및 생물학적 제제의 신속한 스케일업이 가능합니다.
본 조사방법은 정성적, 정량적 방법을 융합하여 조사결과를 다각도로 검증함으로써 견고하고 실용적인 조사결과를 확보하고 있습니다. 1차 조사에서는 제조, 유통, 규제 당국, 생산자 단체 등 다양한 이해관계자를 대상으로 구조화된 인터뷰를 진행했습니다. 이러한 논의는 공급망 의존성, 제품 성능에 대한 우선순위, 규제에 대한 경험, 상업적 기대에 초점을 맞추었습니다. 1차 조사 결과를 보완하기 위해 2차 분석에서는 공개된 규제 관련 문서, 특허 동향, 무역 흐름을 면밀히 조사하여 조달 패턴의 변화를 추적하고 신기술 클러스터를 확인했습니다.
요약하자면, 작물 보호 부문은 규제적 기대, 지속가능성에 대한 요구, 그리고 기술 혁신이 교차하면서 제품 및 공급망 전략을 재정의하는 중요한 분기점에 서 있습니다. 공급처를 다양화하고, 생물학적 유래와 합성 유래를 결합한 하이브리드 솔루션에 투자하고, 정밀한 살포 설계를 위해 제제 설계를 재검토하는 기업은 변화하는 생산자의 요구와 규제적 제약에 대응할 준비가 더 잘 되어 있을 것입니다. 또한, 지역별 제조 및 유통의 탄력성은 관세 충격과 공급 중단에 대한 필수적인 방어책이며, 단기적인 조달 선택과 장기적인 역량 투자에 영향을 미치는 요소입니다.
The Agrochemicals Market was valued at USD 91.00 billion in 2025 and is projected to grow to USD 96.02 billion in 2026, with a CAGR of 6.75%, reaching USD 143.79 billion by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 91.00 billion |
| Estimated Year [2026] | USD 96.02 billion |
| Forecast Year [2032] | USD 143.79 billion |
| CAGR (%) | 6.75% |
Agricultural crop protection remains a foundational element of global food security and supply chain stability. Pesticides and related chemistries protect yields from the combined pressures of pests, pathogens, and competing vegetation, while formulation science and application practices influence both efficacy and environmental footprint. In recent years, the industry has experienced an accelerating convergence of regulatory scrutiny, sustainability expectations, and technological innovation, reshaping how products are developed, registered, and deployed in the field.
Emerging vectors such as resistance management needs, climate-driven pest migration, and shifting consumer preferences toward reduced-residue produce are redefining product portfolios and route-to-market strategies. At the same time, growers and distributors demand higher performing, safer, and more convenient solutions that integrate with precision application systems and agronomic advisory services. Consequently, companies are balancing legacy synthetic chemistries with investments in biologicals, improved adjuvants, and novel delivery mechanisms that reduce dose while preserving performance.
Transition dynamics are further affected by supply chain dependencies for active ingredients, raw material sourcing, and formulation inputs. These pressures have elevated strategic priorities around supplier diversification, regional manufacturing footprints, and inventory planning. Taken together, stakeholders across manufacturing, distribution, and advisory services must navigate a complex environment where regulatory compliance, sustainability commitments, and commercial viability intersect to determine which products advance from pipeline to wide adoption.
The agrochemical landscape is undergoing transformative shifts driven by a combination of technological progress, regulatory tightening, and evolving customer expectations. Precision agriculture technologies are no longer experimental add-ons; they are increasingly integrated into application protocols, enabling more targeted use of active ingredients and reducing off-target impact. This integration has catalyzed demand for formulations engineered for variable-rate application, compatibility with drones and smart sprayers, and improved tank-mix stability. As a result, product development now emphasizes not only intrinsic efficacy but also data compatibility and ease of digital integration.
Simultaneously, the transition toward biologicals and biochemically derived solutions is accelerating. Advances in microbial discovery, fermentation processes, and formulation stabilization have improved the reliability and shelf life of biopesticides. This progression is complemented by improved analytical techniques that enable clearer demonstration of mode-of-action and environmental safety, which in turn eases regulatory pathways in several jurisdictions. Consequently, many companies are pursuing hybrid portfolios that combine lower-dose synthetics with supporting biologicals to manage resistance and meet sustainability criteria.
Regulatory frameworks continue to tighten, especially with respect to environmental risk assessments, worker safety, and residue tolerances. In response, manufacturers are investing more in upstream toxicology and ecotoxicology studies, as well as in product stewardship programs that include applicator training and integrated pest management (IPM) support. These investments are reinforcing the role of advisory services as a differentiator, with leading providers bundling agronomic support, compliance assistance, and traceability tools with product sales.
Another secular change is consolidation in distribution and formulation capabilities. Larger players are integrating downstream channels to control product placement and farmer engagement, while specialized formulators and service providers carve out niches by offering custom blends and on-demand manufacturing. This reconfiguration is increasing competitive intensity in margins and accelerating the need for strategic partnerships and targeted acquisitions. Finally, climate variability and shifting cropping patterns are demanding more flexible chemistries; companies that can rapidly adapt formulations to new pest profiles and tolerate a wider range of environmental conditions will have a competitive edge.
The introduction of tariffs and trade barriers affecting agrochemical inputs in 2025 has materially altered procurement patterns, supply chain strategies, and cost structures across the value chain. Import duties on selected active pharmaceutical ingredients and formulation intermediates have increased the landed cost of many legacy synthetic products, prompting buyers to reassess supplier relationships and to accelerate sourcing diversification. Consequently, procurement teams have intensified efforts to qualify alternative suppliers outside previously dominant trade corridors, while leading manufacturers explore reshoring or regionalizing production to mitigate exposure to elevated cross-border charges.
These tariff-driven dynamics have also influenced inventory planning and contract structures. Firms with flexible production networks have leveraged alternative sites to maintain supply continuity, while those more dependent on a narrow set of suppliers have adopted longer lead times and larger buffer inventories to insulate operations from sudden cost spikes. At the customer level, growers and distributors are negotiating longer-term pricing arrangements and revisiting cost-to-serve models to absorb or pass through higher input costs. In many cases, increased freight and duty expenses have been partially offset by more efficient formulation approaches that reduce active-ingredient usage per hectare.
Regulatory and trade responses have further accelerated strategic interest in biologicals and locally produced formulations. Because many biopesticide supply chains rely on different raw material inputs and shorter transport distances, they have become comparatively less exposed to the specific tariff actions of 2025. As a result, procurement teams and R&D groups have escalated programs focused on microbial and plant-extract-based solutions that can be produced within regional value chains. This trend is supported by investments in fermentation capacity, contract manufacturing partnerships, and localized distribution agreements.
In parallel, the tariffs have intensified M&A and joint-venture activity aimed at securing alternative manufacturing capabilities and distribution access. Strategic buyers are targeting specialized formulators, regional producers, and companies with backward-integrated feedstock capabilities to reduce margin volatility. At the same time, some manufacturers are revising their pricing architecture to offer bundled services-such as logistics guarantees and inventory financing-to retain distributor relationships in the face of rising transactional costs. Collectively, these adjustments reflect a systemic response in which industry participants recalibrate network design, commercial terms, and product portfolios to maintain competitiveness under a higher-tariff regime.
Segment-level dynamics reveal nuanced opportunities and pressures that are informing product development and go-to-market choices across the industry. Within product types, fungicides continue to be dissected into established chemistries such as dithiocarbamates, strobilurins, and triazoles, each with differentiated resistance profiles and application windows that influence portfolio prioritization. Herbicides are evaluated through both pre-emergent and post-emergent lenses, with post-emergent solutions further distinguished by selective and non-selective modes of action; this granularity is critical as growers balance weed resistance management with crop safety and yield optimization. Insecticide segmentation highlights the diversity of active classes including carbamates, neonicotinoids, organophosphates, and pyrethroids, driving differentiated regulatory and stewardship strategies, while rodenticides remain focused between anticoagulant and non-anticoagulant approaches with distinct environmental and non-target risk considerations.
The nature-based segmentation reflects a bifurcation of industry trajectories. Biopesticides-comprising biochemicals, microbial agents, and plant extracts-are gaining traction as registrants and buyers seek lower-residue and environmentally compatible alternatives. Advancements in stabilization and delivery have narrowed performance gaps with synthetic pesticides in many applications, thereby expanding adoption in high-value crops. Conversely, synthetic pesticides continue to play a central role for broad-spectrum efficacy and cost-per-hectare efficiency, particularly where regulatory approvals remain intact and resistance management frameworks require rotation among chemistries.
Crop-type segmentation clarifies demand heterogeneity across cereals and grains, fruits and vegetables, and oilseeds and pulses. Cereal and grain systems often prioritize broad-spectrum herbicides and cost-effective fungicides to protect high-acreage crops, whereas fruits and vegetables demand specialized, lower-residue products and precise application systems to meet food safety standards and consumer preferences. Oilseeds and pulses present additional complexity due to diverse crop rotation schedules and varying susceptibility to specific pest complexes, which elevates the value of integrated solutions combining chemical and biological tools.
Formulation segmentation underscores the continuing relevance of both dry and liquid delivery systems. Dry formulations such as dustable powders, granules, soluble powders, water dispersible granules, and wettable powders offer logistical advantages and suitability for certain crops and climatic conditions, while liquid formulations-including emulsifiable concentrates, soluble liquids, suspension concentrates, and suspo emulsions-are frequently favored for compatibility with modern spraying equipment and for their rapid uptake profiles. Strategic choices between these formats depend on application infrastructure, shelf-life requirements, and the need for co-formulation with adjuvants and biological agents. Taken together, this layered segmentation framework helps companies align R&D investment, regulatory strategies, and commercial execution with distinct grower needs and channel capabilities.
Regional dynamics vary significantly across large geographic clusters, shaping both short-term commercial priorities and longer-term capability investments. In the Americas, agricultural systems often emphasize large-scale mechanized operations and staple crops, creating steady demand for high-efficacy synthetics and adaptable formulation formats. At the same time, sustainability commitments from retailers and food processors are increasing pressure on suppliers to deliver lower-residue options and robust stewardship programs, which in turn fosters adoption of integrated solutions that combine agronomy, advisory services, and product offerings.
In Europe, Middle East & Africa, regulatory complexity and heterogeneous cropping systems require a more localized approach. Europe's stringent environmental and residue standards have encouraged early adoption of biologicals and highly selective chemistries, while regulatory harmonization efforts continue to influence cross-border product registrations. In parts of the Middle East and Africa, infrastructural constraints and varying cold-chain availability shape formulation choices, favoring stable dry formats in some regions and concentrated liquids that can be diluted locally in others. Additionally, pest pressures and cropping patterns in these regions present unique R&D and market-entry considerations that require tailored stewardship and training investments.
Asia-Pacific exhibits a highly diverse tapestry of smallholder and commercial farms, rapid technology adoption in certain markets, and expanding regulatory modernization. High-value horticulture in some Asia-Pacific markets increases demand for low-residue solutions and precise application methods, while the prevalence of small-scale plots often necessitates low-dose, user-friendly formulations and affordable packaging. Rapid urbanization and shifts in dietary patterns are also reconfiguring crop mixes and thereby influencing product portfolio priorities. Across the region, partnerships with local distributors and targeted farmer education programs remain critical to achieving scale and ensuring proper use.
Across all regions, differences in infrastructure, regulatory expectations, and farming practices create opportunities for tailored commercial models. Market players that can align product design, form factor, and advisory services with regional realities will be better positioned to capture demand and to meet evolving sustainability and compliance requirements.
Company strategies reflect a broad spectrum of responses to competitive and regulatory pressures, with leaders pursuing combinations of portfolio diversification, targeted acquisitions, and capability building. Some organizations emphasize deepening their biologicals pipeline, investing in microbial discovery platforms and in-house fermentation capacity to secure differentiated IP and to reduce reliance on external suppliers. Others concentrate on formulation excellence, acquiring or partnering with specialist formulators to deliver co-formulated and low-dose products that perform in precision-application contexts.
A second axis of strategic emphasis is supply chain resilience. Companies are expanding regional manufacturing footprints or securing backward integration for key intermediates to protect against trade disruptions and tariff volatility. This approach often involves long-term contracts with feedstock producers, investments in redundant supply lines, and closer collaboration with logistics partners to stabilize lead times. Concurrently, commercial organizations are refining channel strategies by offering greater technical support, bundled advisory services, and financing options that strengthen distributor relationships and improve product uptake.
On the go-to-market side, firms are strengthening agronomy and stewardship capabilities to differentiate offerings and to comply with tighter regulatory standards. This includes deploying digital advisory tools, building field trial networks, and investing in training programs that help applicators optimize dose and timing. Finally, M&A and alliance activity continues to be a pragmatic route to accelerate access to new technologies, regional distribution networks, and niche product classes. Collectively, these strategic moves are reshaping competitive dynamics and elevating the importance of cross-functional execution from R&D through commercial operations.
Industry leaders should adopt an integrated approach that aligns R&D, supply chain, regulatory engagement, and commercial execution to navigate the sector's complexity effectively. First, prioritize diversification of active-ingredient sources and regional manufacturing capacity to reduce exposure to trade disruptions and to shorten replenishment cycles. Investing in modular production capabilities and strategic contract manufacturing partnerships will create flexibility and reduce lead-time risk while enabling rapid scale-up for high-priority chemistries and biologicals.
Second, accelerate the development of hybrid solutions that pair low-dose synthetics with biological adjuncts to manage resistance and to meet increasing sustainability requirements. R&D teams should emphasize formulation strategies that improve delivery efficiency and compatibility with precision application systems, while also investing in compatibility testing for tank-mix partners. These technical investments will enhance product value propositions and support premium pricing where efficacy and sustainability credentials are demonstrable.
Third, strengthen regulatory intelligence and stewardship programs by integrating early-stage toxicology and environmental assessments into pipeline decision-making. Proactive engagement with regulators and active participation in industry stewardship initiatives will reduce approval risk and improve market access. Complementary to this, build robust agronomic support capabilities and digital advisory platforms to improve adoption, ensure correct use, and create measurable outcomes for growers.
Fourth, redesign commercial models to offer bundled services that address total cost-of-ownership for customers. This can include logistics guarantees, financing for high-value products, and outcome-based contracts where feasible. Lastly, pursue targeted collaborations and M&A to acquire capability gaps-whether in biocontrol expertise, formulation technology, or regional distribution networks-prioritizing assets that accelerate time-to-market and reduce dependency on vulnerable supply chains. Implemented together, these recommendations will strengthen resilience, enable sustainable growth, and create durable differentiation in an evolving competitive landscape.
The research methodology blends qualitative and quantitative techniques to triangulate findings and ensure robust, actionable insights. Primary research included structured interviews with a cross-section of stakeholders across manufacturing, distribution, regulatory agencies, and grower organizations; these discussions focused on supply chain dependencies, product performance priorities, regulatory experience, and commercial expectations. Complementing primary inputs, secondary analysis examined public regulatory filings, patent landscapes, and trade flows to trace shifts in sourcing patterns and to identify emergent technology clusters.
Scenario analysis was used to explore the implications of trade policy changes, climatic variability, and regulatory tightening on product development and distribution strategies. Sensitivity testing around key variables-such as input cost volatility, lead times, and approval timelines-helped identify critical inflection points for strategic decision-making. The study also incorporated geospatial overlays to assess compatibility of formulation formats with regional application infrastructures and to highlight areas where localized production would likely deliver the greatest resilience benefits.
Validation rounds with external experts and field practitioners ensured that findings were grounded in operational realities and that recommended actions were practicable for a range of company sizes and business models. Data integrity measures included cross-referencing proprietary interview insights with open-source trade and regulatory records to mitigate bias and to increase confidence in observed trends. Ultimately, the methodology balances depth of stakeholder engagement with rigorous secondary verification to provide a comprehensive perspective on industry dynamics and strategic responses.
In summary, the crop protection sector stands at a pivotal juncture where regulatory expectations, sustainability imperatives, and technological innovation converge to redefine product and supply chain strategies. Companies that proactively diversify sourcing, invest in hybrid biological-synthetic solutions, and realign formulation design for precision application will be better equipped to meet evolving grower needs and regulatory constraints. Additionally, regional manufacturing and distribution resilience are essential defenses against tariff shocks and supply disruptions, shaping both short-term procurement choices and long-term capability investments.
Strategic emphasis on stewardship, agronomic support, and digital integration will increasingly differentiate market leaders from laggards, as customers reward solutions that deliver demonstrable agronomic and environmental outcomes. Active engagement in regulatory dialogue and targeted acquisitions to fill capability gaps will accelerate time-to-value for new technologies and reduce execution risk. Collectively, these approaches create a pathway to sustainable competitiveness that balances commercial performance with environmental and social responsibilities.
Ultimately, stakeholders who align R&D priorities with regional realities, optimize formulation and application compatibility, and adopt flexible commercial models will capture disproportionate value as the industry transitions. The coming period will favor organizations that combine technical excellence with operational agility and who can translate comprehensive stewardship and advisory services into measurable improvements for growers and supply chain partners.